info@damimedical.com
On November 17th, 2020, Dami Medical Technology Co., Ltd. & Hefei Angel Investment Fund signed the “Capital Increase and Shareholding Agreement”. Hefei Angel is the largest investment organization in Anhui province, and this is the second investing since the first in 2017.
DAMI Medical focuses on the R&D, manufacturing, sales and service of medical devices. The existing products are laid out around airway management products. The purpose is to provide patients with safer and more comfortable medical services and provide convenience and efficiency for clinical medical staff.
DAMI Medical has continuously made breakthroughs and innovations. It has carried out innovation and transformation with well-known domestic universities and hospitals such as the First Affiliated Hospital of University of Science and Technology of China, West China Hospital of Sichuan University, and the First Affiliated Hospital of Zhengzhou University. DAMI Medical has developed and innovated more than five series safety type products, such as laryngeal masks, endoscopic airway, endotracheal tubes, disposable airway, and smart medical care products.
During the epidemic, Dami Medical and CCI (China Cardiovascular Physician Innovation Club) jointly promoted the transformation of anti-epidemic innovation. Completely the design and transformation of the anti-fog goggles, the products have been donated to the anti-epidemic. On the front line, Dami Medical was selected as a key protest material company for anti-epidemic.
In this year, Dami Medical applied for more than 20 invention patents and start the research and development of medical robots. Among them, The anti-spraying tracheal intubation/extubation project was selected as the second batch of special projects for product innovation and industrialization of new coronary pneumonia prevention and treatment; At the same time,”The Supraglottic Airway Management Products” won the Third Prize of Anhui Science and Technology Progress Award in the Science and Technology Award Conference. The projects was organized by the First Affiliated Hospital of the University of Science and Technology of China, and benefits for the comfortable and precise medical.
The research and development of batches products has been widely recognized by medical institutions. The users of Dami’s innovative medical airway products have grown to three hundred public hospitals in domestic. Now with the help of this investment fund, Dami Technology will continue to focus on airway management device, promotes the transformation of scientific and technological achievements, and benefits both doctors and patients.